Program

Transplant and Oncology Infectious Diseases Bundle

Starts Sep 8, 2025
27.75 credits

Sorry! The enrollment period is currently closed. Please check back soon.

Full program description

Department of Medicine, Division of Infectious Diseases

at Johns Hopkins School of Medicine

presents

Transplant and Oncology Infectious Diseases Bundle

Includes the following activities:

  • Transplant and Oncology Infectious Diseases: Live, in-person
  • Advanced Topics in Clinicial Infectious Diseases and Antimicrobial Resistance: Online

These activities has been approved for AMA PRA Category 1 Credits™. 

DESCRIPTION

Infectious diseases remain a dynamic and fascinating field replete with new challenges facing transplant and oncology providers. This activity is designed to explore major infectious diseases topics of particular relevance when caring for transplant and oncology patients.

 

Transplant and Oncology Infectious Diseases
Live, In-Person September 8, 2025
This two-day in-person educational activity will expand expertise on infectious complications in transplant (solid organ and stem cell) and oncology patients. The Transplant and Oncology Infectious Diseases Certificate Course will be held in Washington, DC, and will feature lectures from many of the most respected experts in the field, and provide learners with the knowledge and skills to provide outstanding infectious diseases care to transplant and oncology patients.

 

Advanced Topics in Infectious Diseases and Antimicrobial Resistance
Enduring Material, Online
This online course on advanced topics in infectious diseases is designed to supply primary care providers, residents, infectious disease specialists, hospitalists, and advanced practice providers with a thorough understanding of various infectious diseases commonly encountered in inpatient and outpatient settings. Through five comprehensive online modules, healthcare professionals will develop the knowledge and skills necessary to effectively address, manage, and prevent infectious diseases, while promoting optimal patient outcomes. The program will cover a range of topics, including common inpatient consultations ranging from prosthetic joint infections and osteomyelitis to endocarditis and bloodstream infections. Modules included in depth didactics on the diagnosis and management of transplant and oncology related infectious diseases including invasive fungal infections, herpesviruses, and other opportunistic infections in the immunosuppressed host.  We comprehensively review new IDSA guidelines related to antimicrobial resistance and management of DTR-Pseudomonas, ESBL-producing organisms, KPC and NDM producing organisms, and other common pathogens including Stenotrophomonas and Acinetobacter. 

WHO SHOULD ATTEND

This activity is intended for transplant and oncology and infectious diseases clinicians. Trainees, physicians, surgeons, nurses, pharmacists, and advanced practice providers. Students and Fellows are encouraged to attend.

 

ACCREDITATION STATEMENT

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Activity Maximum Approved Hours

Transplant and Oncology Infectious Diseases Live Activity

16.25

Advanced Topics in Infectious Diseases and Antimicrobial Resistance Enduring Material

11.50

 

For a complete listing of accreditation details by activity, please refer to the individual course listings: 

 

POLICY ON PRESENTER AND PROVIDER DISCLOSURE

It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies in place to identify and mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

An outcome survey will be sent to all physician attendees within two months post activity to assist us in determining what impact this activity had on the learner’s practice.           

FOR FURTHER INFORMATION

Johns Hopkins Department of Medicine, Division of Infectious Disease: https://hopkinsinfectiousdiseases.jhmi.edu/

ACKNOWLEDGEMENT

The Johns Hopkins School of Medicine did not solicit or receive commercial funding from any ineligible companies, including pharmaceutical and medical device manufacturers, for this activity.